Cargando…
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review
Biomarkers associated with the development of comorbidities in atopic dermatitis (AD) patients have been reported, but have not yet been systematically reviewed. Seven electronic databases were searched, from database inception to September 2021. English language randomized controlled trials, prospe...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107168/ https://www.ncbi.nlm.nih.gov/pubmed/36366871 http://dx.doi.org/10.1111/all.15578 |
_version_ | 1785026547610025984 |
---|---|
author | Broderick, Conor Ziehfreund, Stefanie van Bart, Karin Arents, Bernd Eyerich, Kilian Weidinger, Stephan Rastrick, Joseph Zink, Alexander Flohr, Carsten |
author_facet | Broderick, Conor Ziehfreund, Stefanie van Bart, Karin Arents, Bernd Eyerich, Kilian Weidinger, Stephan Rastrick, Joseph Zink, Alexander Flohr, Carsten |
author_sort | Broderick, Conor |
collection | PubMed |
description | Biomarkers associated with the development of comorbidities in atopic dermatitis (AD) patients have been reported, but have not yet been systematically reviewed. Seven electronic databases were searched, from database inception to September 2021. English language randomized controlled trials, prospective and retrospective cohort, and case–control studies that investigated the association between a biomarker and the development of comorbidities in AD patients were included. Two authors independently screened the records for eligibility, one extracted all data, and critically appraised the quality of studies and risk of bias. Fifty six articles met the inclusion criteria, evaluating 146 candidate biomarkers. The most frequently reported biomarkers were filaggrin mutations and allergen specific‐IgE. Promising biomarkers include specific‐IgE and/or skin prick tests predicting the development of asthma, and genetic polymorphisms predicting the occurrence of eczema herpeticum. The identified studies and biomarkers were highly heterogeneous, and associated with predominately moderate‐to‐high risk of bias across multiple domains. Overall, findings were inconsistent. High‐quality studies assessing biomarkers associated with the development of comorbidities in people with AD are lacking. Harmonized datasets and independent validation studies are urgently needed. |
format | Online Article Text |
id | pubmed-10107168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101071682023-04-18 Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review Broderick, Conor Ziehfreund, Stefanie van Bart, Karin Arents, Bernd Eyerich, Kilian Weidinger, Stephan Rastrick, Joseph Zink, Alexander Flohr, Carsten Allergy Review Articles Biomarkers associated with the development of comorbidities in atopic dermatitis (AD) patients have been reported, but have not yet been systematically reviewed. Seven electronic databases were searched, from database inception to September 2021. English language randomized controlled trials, prospective and retrospective cohort, and case–control studies that investigated the association between a biomarker and the development of comorbidities in AD patients were included. Two authors independently screened the records for eligibility, one extracted all data, and critically appraised the quality of studies and risk of bias. Fifty six articles met the inclusion criteria, evaluating 146 candidate biomarkers. The most frequently reported biomarkers were filaggrin mutations and allergen specific‐IgE. Promising biomarkers include specific‐IgE and/or skin prick tests predicting the development of asthma, and genetic polymorphisms predicting the occurrence of eczema herpeticum. The identified studies and biomarkers were highly heterogeneous, and associated with predominately moderate‐to‐high risk of bias across multiple domains. Overall, findings were inconsistent. High‐quality studies assessing biomarkers associated with the development of comorbidities in people with AD are lacking. Harmonized datasets and independent validation studies are urgently needed. John Wiley and Sons Inc. 2022-12-08 2023-01 /pmc/articles/PMC10107168/ /pubmed/36366871 http://dx.doi.org/10.1111/all.15578 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Review Articles Broderick, Conor Ziehfreund, Stefanie van Bart, Karin Arents, Bernd Eyerich, Kilian Weidinger, Stephan Rastrick, Joseph Zink, Alexander Flohr, Carsten Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review |
title | Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review |
title_full | Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review |
title_fullStr | Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review |
title_full_unstemmed | Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review |
title_short | Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review |
title_sort | biomarkers associated with the development of comorbidities in patients with atopic dermatitis: a systematic review |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107168/ https://www.ncbi.nlm.nih.gov/pubmed/36366871 http://dx.doi.org/10.1111/all.15578 |
work_keys_str_mv | AT broderickconor biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT ziehfreundstefanie biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT vanbartkarin biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT arentsbernd biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT eyerichkilian biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT weidingerstephan biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT rastrickjoseph biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT zinkalexander biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT flohrcarsten biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview AT biomarkersassociatedwiththedevelopmentofcomorbiditiesinpatientswithatopicdermatitisasystematicreview |